RxDoctor Payments Data

David Becton

Pediatric Hematology-Oncology · Little Rock, ARNPI 1134219793

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$1,160,725in research payments, 2019–2025

Across 126 payments — averaging $9212.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Jazz Pharmaceuticals Inc.$925K
  • Merck$92K
  • AbbVie$87K
  • Incyte Corporation$21K
  • Takeda Pharmaceuticals U.S.A., Inc.$19K
  • Amgen$9K
  • plus $9K from 2 others

How this compares

Too few pediatric hematology-oncology providers in Arkansasto place this figure against a meaningful peer group, so we don't.

Other pediatric hematology-oncology in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →